| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PetMed Express, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.13 |
| 52 Week High | US$15.08 |
| 52 Week Low | US$3.92 |
| Beta | 0.69 |
| 1 Month Change | -9.83% |
| 3 Month Change | -13.24% |
| 1 Year Change | -70.67% |
| 3 Year Change | -87.25% |
| 5 Year Change | -73.61% |
| Change since IPO | 230.40% |
Recent News & Updates
PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates
Jun 14
PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price
Jun 12Recent updates
PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates
Jun 14PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price
Jun 12A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)
Oct 09PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30
Aug 07The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence
Mar 23PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Feb 10PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Nov 11PetMed Express Puts Are Compelling
Aug 25PetMed Express CFO to leave post today, by remain with company over transition period
Aug 02PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30
Jul 29PetMed Express FQ1 2023 Earnings Preview
Jul 24PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform
Jul 15Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture
Jul 04PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth
May 26PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30
May 13Silver Ring Value Partners - PetMed Express: Squeezed Out Of Obtaining New Customers
Feb 22PetMed Express: Avoid For Now
Jan 17PetMed Express Needs A White Knight
Sep 26PetMed Express (NASDAQ:PETS) Is Increasing Its Dividend To US$0.30
Jul 29Shareholder Returns
| PETS | US Specialty Retail | US Market | |
|---|---|---|---|
| 7D | -4.8% | 0.06% | 1.2% |
| 1Y | -70.7% | 20.4% | 20.8% |
Return vs Industry: PETS underperformed the US Specialty Retail industry which returned 20.3% over the past year.
Return vs Market: PETS underperformed the US Market which returned 20.6% over the past year.
Price Volatility
| PETS volatility | |
|---|---|
| PETS Average Weekly Movement | 8.4% |
| Specialty Retail Industry Average Movement | 6.9% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: PETS has not had significant price volatility in the past 3 months.
Volatility Over Time: PETS's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 302 | Sandra Campos | www.1800petmeds.com |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PetMed Express, Inc. Fundamentals Summary
| PETS fundamental statistics | |
|---|---|
| Market cap | US$82.20m |
| Earnings (TTM) | -US$7.46m |
| Revenue (TTM) | US$281.06m |
0.3x
P/S Ratio-11.0x
P/E RatioIs PETS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PETS income statement (TTM) | |
|---|---|
| Revenue | US$281.06m |
| Cost of Revenue | US$202.42m |
| Gross Profit | US$78.65m |
| Other Expenses | US$86.11m |
| Earnings | -US$7.46m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.38 |
| Gross Margin | 27.98% |
| Net Profit Margin | -2.66% |
| Debt/Equity Ratio | 0% |
How did PETS perform over the long term?
See historical performance and comparison